Skip to content

H2020FP7HORIZON

Charite - Universitaetsmedizin Berlin

Country
DEGermany
Defence projects
0
Projects, all programmes
384
As coordinator
103
EU contribution (CORDIS)
EUR 245,149,807
Active
2008 to 2026

Projects

384 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
NANOGNOSTICSQuantum Dot-Based Highly Sensitive Immunoassays for Multiplexed Diagnostics of Alzheimer's DiseaseFP72009ParticipantEUR 488,700
COME-IN-CARECOmpound 21 and MElatonin in CArdiovascular REmodelingFP72009CoordinatorEUR 121,598
LEISHDNAVAXDevelopment of a DNA vaccine for visceral leishmaniasisFP72009ParticipantEUR 260,100
PERSISTPersisting TransgenesisFP72009ParticipantEUR 20,498
SICA-HFStudies Investigating Co-morbidities Aggravating Heart FailureFP72009CoordinatorEUR 1,567,329
LUPASLuminescent polymers for in vivo imaging of amyloid signaturesFP72009ParticipantEUR 506,144
MITOTARGETMitochondrial dysfunction in neurodegenerative diseases: towards new therapeuticsFP72009ParticipantEUR 174,376
SAFE-TSAFER AND FASTER EVIDENCE-BASED TRANSLATIONFP72009ParticipantEUR 1,300,441
NEUROPTNon-invasive imaging of brain function and disease by pulsed near infrared lightFP72008ParticipantEUR 360,000
EUSTROKEEuropean Stroke Research NetworkFP72008ParticipantEUR 1,099,200
HIVEHyper Interaction Viability ExperimentsFP72008ParticipantEUR 330,810
RISTOMEDNew E-Services for a dietary approach to the elderlyFP72008ParticipantEUR 18,058
METACANCERIdentification and validation of new breast cancer biomarkers based on integrated metabolomicsFP72008CoordinatorEUR 790,680
HAMAMHighly Accurate Breast Cancer Diagnosis through Integration of Biological Knowledge, Novel Imaging Modalities, and ModellingFP72008ParticipantEUR 177,000
EUNEFRONEuropean Network for the Study of Orphan NephropathiesFP72008ParticipantEUR 261,800
ADAPTAdipokines as Drug Targets to Combat Adverse Effects of Excess Adipose TissueFP72008ParticipantNot stated
EUROTRAPSNatural course, pathophysiology, models for early diagnosis, prevention and innovative treatment of TNF Receptor Associated Periodic Syndrome TRAPS with application for all hereditary recurrent feversFP72008ParticipantEUR 106,440
UEPHA-MSUnited Europeans for the Development of Pharmacogenomics in Multiple SclerosisFP72008ParticipantEUR 206,658
FADFighting Aneurysmal DiseasesFP72008ParticipantEUR 562,000
KALADRUG-RNew tools for monitoring drug resistance and treatment response in visceral leishmaniasis in the Indian subcontinentFP72008ParticipantEUR 262,800

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.